| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |